Newsbenzinga
What’s Going On With Biomea Fusion (BMEA) Stock After Hours?
· Published
Article summary
Biomea Fusion reports Phase 1 BMF-650 results, with weight reduction and safety data from its oral GLP-1 drug trial.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…